by Matt Guldin | February 04, 2019
In this webinar, Chilmark Analyst Matt Guldin presents key findings from our report, Bundled Payments: Current Strategies and Tools. Afterward, he and special guest Andrew Tessier (Business Development Director, Signature Medical Group) discuss the financial and strategic implications of bundled payments and the IT options for providers. Key topics addressed: Market
by Matt Guldin | January 23, 2019
Key Takeaways: Walgreens ‘front door to care’ strategy is built around multiple horizontal partnerships. There are questions about how quickly these partnerships can scale to meet investors’ concerns and how Walgreens will monetize them. It is unclear how this new Microsoft partnership announcement fits in with the Walgreens digital consumer
by John Moore | January 21, 2019
Once again, it is that time of the year for our annual pilgrimage to HIMSS. While many attendees focus on the sheer size of the exhibit hall or packing their schedule full of meetings, we wanted to highlight the other major part of the event: education sessions. Below are this
by Chilmark Team | December 10, 2018
The Meaningful Use gravy train finally came to an end in 2018. As the strongest EHR vendors struggle to define new revenue streams, weaker ones faded from view through acquisitions or leveraged buy-out. Meanwhile, funding for 'digital health' start-ups continued to increase, though it likely hit the high water mark
by Chilmark Team | November 29, 2018
As is our custom here, we like to look back on our predictions for the closing year and see just how well we did. Some years we do amazingly well, others we over-reach and miss on quite a few. For 2018, we got seven of our 13 predictions spot-on, two
by Matt Guldin | November 27, 2018
Recent comments by Secretary Alex M. Azar II indicate changes ahead Chilmark recently released a report on the topic of bundles and enabling solutions. To learn more about this research, please click here. Key Takeaways Mandatory alternative payment model (APM) is coming for radiation oncologists. HHS has not yet released
by Chilmark Team | November 15, 2018
By Mark A. Caron, FACHE, CHCIO, Geneia CEO No matter how you look at it, the toll of diabetes and prediabetes is staggering whether you’re the patient, the primary care physician, the employer or the health plan. Nearly 30 million Americans have diabetes. People with diabetes are at increased risk of
by Chilmark Team | November 01, 2018
By Matt Cox (Chief Marketing Officer, Lumeris) and Nigel Ohrenstein (Senior Vice President and head of Market, Lumeris) Health system and health plan leaders across the country are asking the same question: how will our organizations survive and thrive in a value-based world? As the shift to lower-cost settings accelerates
